This paper seems like a pivotal publication for moving idarucizumab forward. I was curious about the research that has led up to this point (as perhaps others may be). How much time was spent conducting in pre-clinical research for idarucizumab and what previous clinical trials have been conducted before this approx. 300 patient study? Has the data from previous studies corroborated the results featured in this study?
Charles Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FCPP
Associate Provost for Innovation in Education at Thomas Jefferson University
Heather Laird-Fick, MD, MPH
Associate Professor of Medicine at Michigan State University College of Human Medicine
Rohan Jotwani, MD/MBA Candidate
MD/MBA Candidate at the Tufts School of Medicine
- All Questions & Answers
- Question: Before the RE-LY Trial?
Time Zone: EST